News

Gov. Greg Gianforte signed a bill eliminating gender and racial balancing for appointments in state-government boards, ...
As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.
In an apparent effort to aid President Trump’s discriminatory clamp down on free speech, Republicans on the House Ways & ...
Moltiply, Italy's price comparison platform, filed a €2.97 billion damages claim against Alphabet's Google search engine on Friday, alleging anti-competitive conduct and abuse of dominance that ...
Price comparison site operator Moltiply Group is suing Alphabet’s Google over what it called anti-competitive behavior.
Researchers at Umeå University, Sweden, and Michigan State University, U.S., have discovered a type of molecule that can kill ...
Goldman Sachs, Pfizer, Coca-Cola and other big names have successfully blocked shareholder resolutions limiting diversity, equity and inclusion efforts. But that doesn’t mean they are DEI champions.
Hoping to banish clingy clothes in dry weather? We tested six anti-static sprays, including some from Static Guard, Bounce, ...
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...
Two new books, 'Girl on Girl' by Sophie Gilbert and 'Bad Friend' by Tiffany Watt Smith, serve as bulwarks against today's ...
Attorney General Dave Yost has approved the language for petitions to bring a repeal of Senate Bill 1 to the ballot.
The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...